Class IITerminatedD-0351-2021
Drug recall · May 5, 2021
PremierZen Black 5000 capsules recall
Why: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
PremierZen Black 5000 capsules, 1 capsule per card/24 capsules per box, Distributed by New Premier Group Los Angeles CA 90006 UPC 7 2817542189 4
- Lots / codes
All lots within expiry
- Quantity
- N/A
- Company
- Namoo Enterprise LLC, Little Ferry, NJ
- Distribution
- Nationwide within the United States
- Initiated
- March 25, 2021 · Voluntary: Firm initiated
- Classified
- April 26, 2021
- Reported
- May 5, 2021
- Ended
- July 16, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.